Expert Committee on Drug Dependence Information Repository

Substance Records

( (7) | 1 (12) | 2 (16) | 3 (18) | 4 (21) | 5 (10) | 6 (2) | 7 (2) | A (33) | B (23) | C (22) | D (32) | E (13) | F (14) | G (3) | H (6) | I (1) | J (3) | K (4) | L (5) | M (33) | N (26) | O (5) | P (32) | Q (1) | R (2) | S (3) | T (16) | U (2) | V (3) | X (1) | Z (4)
Title Drug Class Year(s) and type of review / ECDD meetings
Cannabidiol (CBD) cannabinoid 39th ECDD (2017) - Pre-review/a> , 40th ECDD (2018) – Pre-review
Cannabidiol preparations cannabinoid 41st ECDD (2018) - Critical review
Cannabis and cannabis resin cannabinoid 40th ECDD (2018) – Pre-review , 41st ECDD (2018) - Critical review
Carbromal sedative 24th ECDD (1988) - Critical review
Carbromide sedative 25th ECDD (1989) - Critical review
Carfentanil opioid 39th ECDD (2017) – Pre-review
Carisoprodol sedative 32nd ECDD (2001) – Pre-review, 46th ECDD (2023) – Pre-review
Cathine stimulant 22nd ECDD (1985) - Critical review
Cathinone stimulant 22nd ECDD (1985) - Critical review
Chloralodol sedative 24th ECDD (1988) - Critical review
Clobenzorex stimulant 22nd ECDD (1985) - Critical review
Clomethiazole sedative 24th ECDD (1988) - Critical review
Clonazolam benzodiazepine 43rd ECDD (2020) - Critical review
Clonidine other 25th ECDD (1989) - Critical review
Clonitazene opioid 11th ECDD (1961) - Critical review
Coca leaf stimulant 28th ECDD (1993) - Pre-review
Crotonylfentanyl opioid 42nd ECDD (2019) - Critical review
CUMYL-4CN-BINACA cannabinoid 41st ECDD (2018) - Critical review
CUMYL-PEGACLONE cannabinoid 43rd ECDD (2020) - Critical review
Cyclopentobarbital sedative 23rd ECDD (1987) - Critical review
Cyclopropylfentanyl opioid 41st ECDD (2018) - Critical review
Cyprenorphine opioid 15th ECDD (1966) - Critical review